News Summary: Baxter to buy Gambro in $2.76B deal

(AP) - THE DEAL: Drug and medical device maker Baxter International Inc. said Tuesday it plans to buy the privately held Swedish company Gambro AB for about $2.76 billion. The deal is worth about $4 billion, counting debt.

THE REASONING: Baxter wants to broader its dialysis product portfolio. Dialysis involves removing blood from a patient, running it through a machine that cleans out impurities and then returning it to the patient's body.

ABOUT BAXTER: Based in Deerfield, Ill., Baxter also makes vaccines, bleeding disorder treatments and intravenous administration sets to deliver medicines and fluids to patients.


(Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)

Top Stories

  • It's a Red Light
    Why isn't Seattle making better use of the all-way-walk to solve traffic woes?

  • History of Seafair
    We take a look back at how Seafair became a Seattle tradition
ATTENTION COMMENTERS: We've changed our comments, but want to keep you in the conversation.
Please login below with your Facebook, Twitter, Google+ or Disqus account. Existing MyNorthwest account holders will need to create a new Disqus account or use one of the social logins provided below. Thank you.
comments powered by Disqus
Sign up for breaking news e-mail alerts from MyNorthwest.com
In the community
Do you know an exceptional citizen who has impacted and inspired others?
KIRO Radio and WSECU would like to recognize six oustanding citizens this year. Nominate them to be recognized and to receive a $2,000 charitable grant.